Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

VKORC1 -1639 G>A Polymorphism in Romanian Patients With Deep Vein Thrombosis.

Vesa ŞC, Trifa AP, Crişan S, Buzoianu AD.

Clin Appl Thromb Hemost. 2016 Nov;22(8):760-764. Epub 2015 May 13.

PMID:
25976278
2.

The PAI-1 gene 4G/5G polymorphism and deep vein thrombosis in patients with inherited thrombophilia.

Sartori MT, Danesin C, Saggiorato G, Tormene D, Simioni P, Spiezia L, Patrassi GM, Girolami A.

Clin Appl Thromb Hemost. 2003 Oct;9(4):299-307.

PMID:
14653439
3.

Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis.

Akhter MS, Biswas A, Ranjan R, Meena A, Yadav BK, Sharma A, Saxena R.

Clin Appl Thromb Hemost. 2010 Apr;16(2):184-8. doi: 10.1177/1076029609333673. Epub 2009 May 5.

PMID:
19419975
4.
5.

Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence.

Sundquist K, Wang X, Svensson PJ, Sundquist J, Hedelius A, Larsson Lönn S, Zöller B, Memon AA.

Thromb Haemost. 2015 Nov 25;114(6):1156-64. doi: 10.1160/TH15-01-0031. Epub 2015 Aug 6.

PMID:
26245493
6.

The influence of factor V Leiden and G20210A prothrombin mutation on the presence of residual vein obstruction after idiopathic deep-vein thrombosis of the lower limbs.

Cosmi B, Legnani C, Pengo V, Ghirarduzzi A, Testa S, Poli D, Prisco D, Tripodi A, Palareti G; PROLONG Investigators (on behalf of FCSA, Italian Federation of Anticoagulation Clinics).

Thromb Haemost. 2013 Mar;109(3):510-6. doi: 10.1160/TH12-01-0041. Epub 2013 Jan 10.

PMID:
23306310
7.

Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia.

Martinelli I, Battaglioli T, Razzari C, Mannucci PM.

J Thromb Haemost. 2007 Jan;5(1):98-101. Epub 2006 Oct 25.

8.

Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.

Aznar J, Vayá A, Estellés A, Mira Y, Seguí R, Villa P, Ferrando F, Falcó C, Corella D, España F.

Haematologica. 2000 Dec;85(12):1271-6.

9.

Association between inherited thrombophilia and impaired right ventricular function in deep vein thrombosis without symptomatic pulmonary embolism.

Asgun HF, Kirilmaz B, Saygi S, Ozturk O, Silan F, Karatag O, Kosar S, Ozdemir O.

Clin Appl Thromb Hemost. 2014 Apr;20(3):270-7. doi: 10.1177/1076029612460426. Epub 2012 Sep 18.

PMID:
22992348
10.

Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.

Martinelli I, Battaglioli T, Bucciarelli P, Passamonti SM, Mannucci PM.

Circulation. 2004 Aug 3;110(5):566-70. Epub 2004 Jul 19.

PMID:
15262837
11.

Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis.

Coulam CB, Wallis D, Weinstein J, DasGupta DS, Jeyendran RS.

Am J Reprod Immunol. 2008 Nov;60(5):426-31. doi: 10.1111/j.1600-0897.2008.00640.x.

PMID:
18803625
12.
13.

Thrombophilia testing in patients with venous thrombosis.

Caprini JA, Goldshteyn S, Glase CJ, Hathaway K.

Eur J Vasc Endovasc Surg. 2005 Nov;30(5):550-5. Epub 2005 Aug 1.

14.

Hereditary and acquired thrombophilia in patients with upper extremity deep-vein thrombosis. Results from the MAISTHRO registry.

Linnemann B, Meister F, Schwonberg J, Schindewolf M, Zgouras D, Lindhoff-Last E; MAISTHRO registry.

Thromb Haemost. 2008 Sep;100(3):440-6.

PMID:
18766260
15.

Vitamin K epoxide reductase genetic polymorphism is associated with venous thromboembolism: results from the EDITH Study.

Lacut K, Larramendy-Gozalo C, Le Gal G, Duchemin J, Mercier B, Gourhant L, Mottier D, Becquemont L, Oger E, Verstuyft C.

J Thromb Haemost. 2007 Oct;5(10):2020-4.

16.

VKORC1 and CYP2C9 genotypes in Egyptian patients with warfarin resistance.

Azzam H, Elwakeel H, Awad I, El-Farahaty R, El-Gilany AH, El-Sharawy S.

Blood Coagul Fibrinolysis. 2016 Mar;27(2):121-6. doi: 10.1097/MBC.0000000000000168.

PMID:
24978953
17.

The Contributions of Thrombophilic Mutations to Genetic Susceptibility to Deep Venous Thrombosis in Iraqi Patients.

Al-Allawi NA, Badi AI, Goran MA, Nerweyi FF, Ballo HM, Al-Mzury NT.

Genet Test Mol Biomarkers. 2015 Sep;19(9):500-4. doi: 10.1089/gtmb.2015.0099. Epub 2015 Jul 21.

PMID:
26196588
18.

The role of point mutations in the genes, predisposing inherited thrombophilia in the pathogeneses of proximal and distal deep vein thrombosis in Georgian population.

Pirtskhelani N, Kochiashvili N, Makhaldiani L, Pargalava N, Gaprindashvili E, Kartvelishvili K.

Georgian Med News. 2014 Feb;(227):98-102.

PMID:
24632657
19.

Deep venous thrombosis and thrombophilic mutations in western Iran: association with factor V Leiden.

Rahimi Z, Mozafari H, Shahriari-Ahmadi A, Alimogaddam K, Ghavamzadeh A, Aznab M, Mansouri K, Rezaei M, Parsian A.

Blood Coagul Fibrinolysis. 2010 Jul;21(5):385-8. doi: 10.1097/MBC.0b013e328330e69a.

PMID:
20479641
20.

Common C677T polymorphism in the methylenetetrahydrofolate reductase gene increases the risk for deep vein thrombosis in patients with predisposition of thrombophilia.

Fujimura H, Kawasaki T, Sakata T, Ariyoshi H, Kato H, Monden M, Miyata T.

Thromb Res. 2000 Apr 1;98(1):1-8.

PMID:
10706928

Supplemental Content

Support Center